Semaglutide Injection Pen 

[Indications]
It is suitable for the treatment of type 2 diabetes mellitus in adults as an adjunct to diet and exercise to improve glycemic control. It is also indicated for chronic weight management in adults with obesity or overweight with at least one weight-related condition, when used together with a reduced-calorie diet and increased physical activity.

[Usage and dosage]
This product is administered by subcutaneous injection once weekly. The recommended starting dose is 0.25 mg once weekly for 4 weeks, followed by an increase to 0.5 mg once weekly. The dose may be gradually increased according to clinical response and tolerability. The injection can be administered in the abdomen, thigh, or upper arm, and the injection site should be rotated.